Sanofi-Aventis wins US approval to extend meningitis vaccine to young children |
|
|
|
Published
:
Fri, 19 Oct 2007 14:44
|
PARIS (Thomson Financial) - Sanofi-Aventis said its Sanofi Pasteur unit has won the approval of the US Food and Drug Administration (FDA) to extend its licence for meningitis vaccine Menactra to children of 2-10 years of age.Sanofi Pasteur filed its application for the Menactra licence extension in March 2005 after receiving its initial licence for 11-55 year olds in January 2005.tfn.paris@thomson.comgt/ak/gt/sljCOPYRIGHTCopyright Thomson Financial News Limited 2007. All rights reserved.The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.
|
|
|
|
|
|
|
| Stock
Quotes * |
|
NASDAQ
|
|
1398.07 |
-137.50 (
-8.95 %)
|
| SYMBOL (
2007-09-26 ) |
| LAST |
CHANGE
|
|
HANSON
(
12:41pm )
|
|
1099.00 |
+3.00 (
0.27 %)
|
|
AMVESCAP
(
11:35am )
|
|
607.50 |
+2.50 (
0.41 %)
|
| SYMBOL (
2008-12-01 )
|
| LAST |
CHANGE
|
|
INTEL CP
(
4:00pm ) |
|
12.56 |
-1.24 (
-9.16 %)
|
| SYMBOL (
2007-09-04 )
|
| LAST |
CHANGE
|
|
|
Print this Story
Sanofi Aventis counter sues against Ypsomed in patent infringement case 